Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Paul Mayhew-Archer visited the Oxford Parkinson's Disease Centre (OPDC) to find out more about our cutting edge research.

Parkinson's

After being diagnosed with Parkinson's five years ago, comedy writer Paul Mayhew-Archer decided to investigate what research was being done into pioneering new treatments for the disease. In the last few months, Paul has visited the OPDC where researchers are trying to determine the molecular pathways of Parkinson's disease.

The result of his visits: 'Parkinson's: The Funny Side' was shown on BBC One on Monday 7th March and is available to view on iPlayer until 6th April 2016. 

Paul was joined by DPAG's  Professor Richard Wade-Martins, Principal Investigator of the OPDC, who talked about our research using stem cell technology to grow and study dopamine neurons from Parkinson's patients' skin cells to identify potential targets for treatments. The BBC One Saturday Breakfast News clip can be viewed here.

Similar stories

Oxford Parkinson’s Disease Centre host the 2022 Oxford Parkinson’s Research Day

On Tuesday 29th November 2022, Professor Richard Wade-Martins and Professor Michele Hu from the Oxford Parkinson’s Disease Centre (OPDC) hosted the Oxford Parkinson’s Research Day at the Kavli Institute for Nanoscience Discovery, Dorothy Crowfoot Hodgkin Building, South Parks Road, Oxford.

New study shows clinical symptoms for Alzheimer’s can be predicted in preclinical models

Establishing preclinical models of Alzheimer’s that reflect in-life clinical symptoms of each individual is a critically important goal, yet so far it has not been fully realised. A new collaborative study from the University of Oxford has demonstrated that clinical vulnerability to an abnormally abundant protein in Alzheimer’s brain is in fact reflected in individual patient induced pluripotent stem cell-derived cortical neurons.

How desk jobs alter your brain – and why they’re so tiring

A fascinating new article on The Conversation website by DPAG's Professor Zoltán Molnár and Professor Tamas Horvath from Yale University.

DPAG Myth Busters and Shaping Destiny teams engage the public at IF Oxford 2022

Two DPAG-led teams of volunteers engaged hundreds of visitors at Wesley Memorial Church on Saturday 8 October 2022 as part of The Oxford Science and Ideas Festival’s Explorazone. The Myth Busters team assembled by DPAG’s Outreach and Public Engagement Working Group sought to discuss and debunk myths and misconceptions of biology. The Shaping Destiny team run by members of the Srinivas Group, IDRM, in collaboration with Prof Wes Williams at TORCH explored with the public what is human and how body forms have been historically perceived with a unique virtual reality experience.

BHF funded DPAG projects to receive share of £2 million raised by the London Marathon

The British Heart Foundation were charity of the year for the 2022 TCS London Marathon. Around 800 BHF London Marathon runners, including former De Val lab researcher Dr Alice Preston, have raised nearly £2 million, and rising, for BHF-funded science that could lead to improved new treatments for heart failure. Research led by Associate Professor Sarah De Val and Dr Joaquim Vieira are two of eight projects to receive funding from these proceeds.